DEUTSCHE BANK AG\ - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$482,000
-22.6%
4,070
-22.8%
0.00%
Q4 2020$623,000
-96.9%
5,269
-97.0%
0.00%
-100.0%
Q3 2020$19,824,000
+20128.6%
178,381
+18442.7%
0.01%
Q2 2020$98,000
-90.9%
962
-90.4%
0.00%
-100.0%
Q1 2020$1,081,000
+17916.7%
10,008
+15063.6%
0.00%
Q4 2019$6,000
-25.0%
66
-21.4%
0.00%
Q3 2019$8,000
-80.0%
84
-80.3%
0.00%
Q2 2019$40,000
-67.2%
427
-68.4%
0.00%
Q1 2019$122,000
+3966.7%
1,351
+2602.0%
0.00%
Q4 2018$3,000
-62.5%
50
-50.0%
0.00%
Q3 2018$8,000
-99.9%
100
-99.9%
0.00%
-100.0%
Q2 2018$13,308,000
+630.8%
133,983
+495.5%
0.00%
+300.0%
Q1 2018$1,821,000
-61.4%
22,500
-62.4%
0.00%
-66.7%
Q4 2017$4,716,000
-63.4%
59,873
-57.2%
0.00%
-66.7%
Q3 2017$12,895,000139,7670.01%
Other shareholders

There were no reported owners of CHINA BIOLOGIC PRODS HLDGS I in Q2 2021.

NameSharesValueWeighting ↓
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders